These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24769763)

  • 1. Eli Lilly agrees to acquire Novartis Animal Health.
    Vet Rec; 2014 Apr; 174(17):417. PubMed ID: 24769763
    [No Abstract]   [Full Text] [Related]  

  • 2. Elanco completes acquisition of Novartis.
    Vet Rec; 2015 Jan; 176(2):41. PubMed ID: 25573871
    [No Abstract]   [Full Text] [Related]  

  • 3. Elanco moves to acquire Janssen.
    Vet Rec; 2011 Apr; 168(13):342. PubMed ID: 21498232
    [No Abstract]   [Full Text] [Related]  

  • 4. Biologics industry challenges for developing diagnostic tests for the National Veterinary Stockpile.
    Hardham JM; Lamichhane CM
    Dev Biol (Basel); 2013; 135():39-52. PubMed ID: 23689882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. US industry engages with voluntary AMR initiative.
    Vet Rec; 2014 Jul; 175(2):34. PubMed ID: 25013191
    [No Abstract]   [Full Text] [Related]  

  • 6. Eli Lilly enters venture capital arena.
    Fletcher L
    Nat Biotechnol; 2001 Nov; 19(11):997-8. PubMed ID: 11689830
    [No Abstract]   [Full Text] [Related]  

  • 7. Eli Lilly settles corrupt foreign practices complaint for $29.4m.
    Roehr B
    BMJ; 2012 Dec; 345():e8694. PubMed ID: 23271750
    [No Abstract]   [Full Text] [Related]  

  • 8. On back order.
    Burns K
    J Am Vet Med Assoc; 2010 Nov; 237(10):1104-7. PubMed ID: 21073378
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of the pharmaceutical industry in drug development and approval.
    Beleau MH
    Vet Hum Toxicol; 1998; 40 Suppl 2():17-9. PubMed ID: 9823577
    [No Abstract]   [Full Text] [Related]  

  • 10. Deals landscape: notable deals in the pharmaceutical industry in the first quarter of 2008.
    Shumoogam J; Al-Shamahi A
    IDrugs; 2008 May; 11(5):351-5. PubMed ID: 18465677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schering-Plough agrees to pay FDA $500 million and bring factories into compliance.
    Kuehn BM
    J Am Vet Med Assoc; 2002 Jul; 221(2):174, 180. PubMed ID: 12118571
    [No Abstract]   [Full Text] [Related]  

  • 12. The Minor Use and Minor Species Animal Health Act: past, present, and future.
    Haley CJ
    Food Drug Law J; 2006; 61(1):13-43. PubMed ID: 16838456
    [No Abstract]   [Full Text] [Related]  

  • 13. The CEO of Novartis on growing after a patent cliff.
    Jimenez J
    Harv Bus Rev; 2012 Dec; 90(12):39-42, 135. PubMed ID: 23227577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Launch of new company represents 'more than a change of name'.
    Vet Rec; 2013 Mar; 172(11):280. PubMed ID: 23504158
    [No Abstract]   [Full Text] [Related]  

  • 15. Sales of contaminated animal drugs halted.
    Henkel J
    FDA Consum; 1999; 33(5):34. PubMed ID: 10522171
    [No Abstract]   [Full Text] [Related]  

  • 16. Eli Lilly: correction and apology.
    BMJ; 2005 Jan; 330(7485):211. PubMed ID: 15677638
    [No Abstract]   [Full Text] [Related]  

  • 17. Merial - Intervet/Schering-Plough merger terminated.
    Vet Rec; 2011 Apr; 168(13):338. PubMed ID: 21498224
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug information services at Eli Lilly and Company.
    Pfeil-Doyle JL; Jones MD; Oberlin JA; Benitez J
    Am J Hosp Pharm; 1990 Sep; 47(9):1996-8. PubMed ID: 2220850
    [No Abstract]   [Full Text] [Related]  

  • 19. Norbrook plans to stay independent.
    Vet Rec; 2014 Nov; 175(17):416. PubMed ID: 25359736
    [No Abstract]   [Full Text] [Related]  

  • 20. Responsible extra-label use of drugs.
    Cobb DV
    J Am Vet Med Assoc; 1996 Nov; 209(9):1545. PubMed ID: 8899012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.